SCHEMBL5795314

SCHEMBL5795314

CCCCOC(=O)C1CCN(c2cc(-c3ccc(-c4ccccc4C=O)cc3)nc3cc(OC)ccc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
TDP1 Q9NUW8 2/20 0.45
MAPT P10636 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPK1 P28482 3/20 0.40
GAA P10253 2/20 0.40
TSHR P16473 2/20 0.40
HPGD P15428 2/20 0.40
CASP1 P29466 2/20 0.40
HSD17B10 Q99714 2/20 0.40
PLA2G2A P14555 2/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5795770 0.86 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1TDP1MAPT
SCHEMBL5819962 0.84 MOK (0.51) ALDH1A1KMT2AMEN1TDP1KDM4E
SCHEMBL5794261 0.82 ALDH1A1 (0.57) ALDH1A1KMT2AMEN1TDP1MAPT
SCHEMBL5797448 0.78 ALDH1A1 (0.62) ALDH1A1KMT2AMEN1TDP1MAPT
SCHEMBL8269894 0.77 KMT2A (0.50) ALDH1A1KMT2AMEN1TDP1KDM4E
SCHEMBL8268928 0.75 ALDH1A1 (0.55) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL8270124 0.72 MOK (0.56) ALDH1A1KMT2AMEN1TDP1KDM4E
SCHEMBL8270102 0.72 PDE10A (0.54) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL8268926 0.70 KDM4E (0.51) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL10992611 0.69 MAPT (0.57) ALDH1A1KMT2AMEN1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006034512-A2 PHENYL-SUBSTITUTED QUINOLINE AND QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2006-03-30 WO disclosed
WO-2006034512-A2 PHENYL-SUBSTITUTED QUINOLINE AND QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2006-03-30 WO disclosed
WO-2006034491-A2 PHENYL-SUBSTITUTED QUINOLINE AND QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2006-03-30 WO disclosed